After COVID, The US Is Turning To The Same Organization To Fight Ebola In DR Congo

After COVID, The US Is Turning To The Same Organization To Fight Ebola In DR Congo

Credit: iStock

Text

Updated Jun 25, 2026 | 10:00 PM IST

SummaryThe U.S. is supplying experimental Ebola drug MBP134 for clinical trials in Congo's growing outbreak, marking a policy shift as researchers test potential treatments for the deadly Bundibugyo strain.

End of Article